SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001654954-21-002284
Filing Date
2021-03-03
Accepted
2021-03-03 16:15:39
Documents
5
Period of Report
2021-04-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A edsa_def14a.htm DEF 14A 652002
2 IMAGE edsa_proxy1000.jpg GRAPHIC 74606
3 IMAGE edsa_proxy1001.jpg GRAPHIC 60671
4 IMAGE edsa_proxy2000.jpg GRAPHIC 69359
5 IMAGE edsa_proxy2001.jpg GRAPHIC 72627
  Complete submission text file 0001654954-21-002284.txt   1035368
Mailing Address 100 SPY COURT MARKHAM A6 L3R 5H6
Business Address 100 SPY COURT MARKHAM A6 L3R 5H6 (905) 475-1234
Edesa Biotech, Inc. (Filer) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37619 | Film No.: 21709143
SIC: 2834 Pharmaceutical Preparations